News

The Chemical Industry and EPA: A Broken System?

The Chemical Industry and EPA: A Broken System?

Decades of an Unchecked Revolving Door

The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler for oversight, says it's gotta stop.

Why does it matter? It's the trust—or lack thereof. When ex-industry bigwigs make calls on chemical safety, can we trust they're looking out for us and not their old pals? Baum puts it plainly: the EPA should be all about serving the folks in harm's way, not those with boardroom ties.

A Political Tug-of-War Unheeded

Does it matter if the White House is red or blue when chemical industry suits keep showing up in high places at the EPA? Both parties have let this merry-go-round spin unchecked. And Baum sees it as a core issue. Regulatory capture—sounds fancy, but it's basically industry whispering sweet nothings into regulation's ear. Look at past EPA Office of Pesticide Programs directors who cozied up with giants like Monsanto and DuPont.

A deeper dive shows that meetings with industry reps far outpace those with environmental or health advocates. And surprise, surprise—industry reps were ushered through the front door more often than not.

Industry-Funded Science: Who’s Fooling Who?

Remember the science backing chemical safety? Well, guess who's paying for it! The very same companies looking to reap the rewards. All too familiar, right? This cocktail of industry ties and corporate-backed studies makes the whole regulation process look like one bad magic trick.

"The revolving door and industry-funded science reinforce each other," Baum highlights. It's like having the fox and hens run the yard.

Roundup and the Ghosts of Frauds Past

Dive into Wisner Baum's Roundup lawsuits to see how deep these cracks go. Turns out Monsanto had its sticky fingers in scientific studies and tried to undercut independent researchers. Talk about stacking the deck. Ever hear of Paul Wright? He cooked the books, got caught, but Monsanto had the pocket change to cover it. Fast forward, and we see lawsuits upending the EPA's glyphosate analysis—another chapter in regulatory confusion.

  • Internal emails reveal efforts to quash unfavorable studies.
  • Now-famous "Monsanto Papers" expose behind-the-scenes influence.

Wisner Baum is adamant—this needs a solid response, not just a slap on the wrist.

Wisner Baum’s Roadmap for Reform

Fancy some transparency? Wisner Baum is pushing for longer cooling-off periods for ex-industry types joining the EPA. Why not make corporate communications public? Let's see who’s bending who's ear.

"The public should not need cancer victims, subpoenas, and years of litigation to discover that supposedly independent science was shaped behind the scenes," insists Baum.

Charting a New Course

And not just paperwork. More funding for bona fide independent toxicology too. No more giving manufacturers the keys to the lab without keeping everything out in the open. Baum argues it's about time Congress steps up and funds real independent research.

In the end, it's not just about regulatory rules, but about real people's lives and health. With Wisner Baum calling for these changes, the hope is to shift the narrative from spreadsheets and lobbyist whisper strategies to genuine public safety.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading

Top 5 Most Recently Viewed Articles

Hillwood Launches New Industrial Project on Kuser Road

Updated Category News Views 166

Hillwood's New Industrial Development Hillwood, a prominent player in the industrial real estate sector, has made a significant move with the groundbreaking of a new project on Kuser Road. This development spans 36 acres and is a part of Hillwood's strategy to enhance its portfolio in key logistics markets. The site, strategically located within a major logistics hub,...

Continue Reading
 Transforming $100 into Over $2,000: A Stock Journey

Updated Category News Views 197

The Growth of Insulet Corporation Over 15 Years Insulet Corporation (NASDAQ: PODD) has been a shining star in the stock market, consistently outperforming expectations and providing impressive returns to investors. Over the last 15 years, the company has exhibited an annualized return of 22.42%, surpassing the market by an impressive margin of 9.72%. Their current market...

Continue Reading
TRESU Investment Holding A/S Revises 2025 Financial Forecast

Updated Category News Views 203

TRESU Investment Holding A/S Adjusts Full Year 2025 Guidance TRESU Investment Holding A/S has recently announced a revision to its financial projections for the year 2025. This adjustment primarily stems from a noticeable slowdown in market demand, which has affected both the Systems and Machine & Units segments of the company, prompting a reevaluation of growth...

Continue Reading
Matson, Inc. Announces Participation in Major Logistics Event

Updated Category News Views 132

Matson to Attend Key Transportation and Logistics Conference Matson, Inc. (NYSE: MATX) is set to be a prominent participant at the upcoming Stifel Transportation & Logistics Conference. The event promises to be a significant gathering for industry leaders, with Matson's own CEO, Matt Cox, slated to attend. This participation exemplifies Matson's commitment to...

Continue Reading
Questerre Energy's Exciting Consolidation of Red Leaf Resources

Updated Category News Views 211

Questerre Energy's Bold Step Forward Questerre Energy Corporation (TSX: QEC) has announced a pivotal move to consolidate its interests in Red Leaf Resources, a strategic decision aimed at strengthening its position in the oil and gas market. By exchanging common shares from Red Leaf for its own Class "A" Common voting shares, Questerre aims to complete the acquisition of...

Continue Reading